NASDAQ:GNPX

Genprex Stock Insider Trading

etoro logo Buy GNPX
*Your capital is at risk
$0.720
-0.0153 (-2.08%)
At Close: Jun 03, 2026

Genprex Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 70.19. In total, the insiders bought 12.33M and sold 49.2K GNPX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
70.19
Buy 12.33M shares
Sell 49.2K shares
82% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
Feb 27, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 70.19.
  • Confidence increased due to high data reliability score of 80.

Historical Insider Trades

Date Type Person Role Amount
Dec 05, 2024
Buy
Common Stock
A-Award
Wilson William R Jr.
Director
Director 4 750
Value: $5K
Dec 05, 2024
Buy
Common Stock
A-Award
Moreno Toscano Jose Antonio
Director
Director 4 750
Value: $5K
Feb 18, 2024
Sell
Common Stock
F-InKind
Berger Mark Stanley
Chief Medical Officer
Officer 1 319
Value: $6K
Feb 18, 2024
Sell
Common Stock
F-InKind
Varner John Rodney
Chairman, President And CEO
CEO / President 2 642
Value: $11.6K
Feb 18, 2024
Sell
Common Stock
F-InKind
Confer Ryan M.
Chief Financial Officer
C-Suite Officer 1 126
Value: $5K
Feb 18, 2024
Sell
Common Stock
F-InKind
Confer Ryan M.
Chief Financial Officer
C-Suite Officer 1 126
Value: $5K
Feb 18, 2024
Sell
Common Stock
F-InKind
Varner John Rodney
Chairman, President And CEO
CEO / President 2 642
Value: $11.6K
Feb 18, 2024
Sell
Common Stock
F-InKind
Berger Mark Stanley
Chief Medical Officer
Officer 1 319
Value: $6K
Jun 27, 2023
Buy
Common Stock
A-Award
Moreno Toscano Jose Antonio
Director
Director 123 795
Value: $0
Jun 27, 2023
Buy
Common Stock
A-Award
Longnecker Brent M
Director
Director 123 795
Value: $0
Jun 27, 2023
Buy
Common Stock
A-Award
Wilson William R Jr.
Director
Director 123 795
Value: $0
Jun 27, 2023
Buy
Common Stock
A-Award
Wilson William R Jr.
Director
Director 123 795
Value: $0
Jun 27, 2023
Buy
Common Stock
A-Award
Longnecker Brent M
Director
Director 123 795
Value: $0
Jun 27, 2023
Buy
Common Stock
A-Award
Moreno Toscano Jose Antonio
Director
Director 123 795
Value: $0
Apr 21, 2023
Buy
Common Stock
P-Purchase
Varner John Rodney
Chairman, President And CEO
CEO / President 19 000
Value: $20.0K
Apr 21, 2023
Buy
Common Stock
P-Purchase
Varner John Rodney
Chairman, President And CEO
CEO / President 19 000
Value: $20.0K
Apr 21, 2023
Buy
Common Stock
P-Purchase
Vaczy Catherine M
EVP GC Chief Strategy Officer
Officer 20 000
Value: $21.5K
Apr 21, 2023
Buy
Common Stock
P-Purchase
Vaczy Catherine M
EVP GC Chief Strategy Officer
Officer 20 000
Value: $21.5K
Feb 18, 2023
Buy
Common Stock
A-Award
Vaczy Catherine M
EVP GC Chief Strategy Officer
Officer 245 000
Value: $0
Feb 18, 2023
Buy
Common Stock
A-Award
Berger Mark Stanley
Chief Medical Officer
Officer 245 000
Value: $0
Feb 18, 2023
Buy
Common Stock
A-Award
Kumar Hermant
Chief Mfgr & Tech Officer
Officer 200 000
Value: $0
Feb 18, 2023
Buy
Common Stock
A-Award
Confer Ryan M.
Chief Financial Officer
C-Suite Officer 245 000
Value: $0
Feb 18, 2023
Buy
Common Stock
A-Award
Varner John Rodney
President & CEO
CEO / President 625 000
Value: $0
Feb 18, 2023
Buy
Common Stock
A-Award
Varner John Rodney
President & CEO
CEO / President 625 000
Value: $0
Feb 18, 2023
Buy
Common Stock
A-Award
Confer Ryan M.
Chief Financial Officer
C-Suite Officer 245 000
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT GENPREX INC.
Genprex
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas....
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE